Churchill Capital Corp XI CCXI
11.26 USD +0.57 (+5.33%)
At closeNov 4, 2026, 4:00 PM EST
11.60 +0.34 +3.02%
After hours · Nov 4, 4:00 PM ET
10.81 Day range 12.17
8.00 52-week range 19.69
- YTD
- 0.00%
- 1 year
- 0.00%
News
seekingalpha.com Agility Robotics: Market Jitters Presenting A Golden Opportunity Shareholders have approved the merger between Churchill Capital Corp. XI Cl A and the industrial robotics company Agility Robotics. For investors who don't have access to Chinese stocks that don't…
fool.com The SPAC Sponsor Behind Lucid and Oklo Is Taking Agility Robotics Public on Nov. 5. Here's What Those 2 Stocks Did in Their First 90 Days. The robotics stock could see wild swings after its public debut.
benzinga.com Reported November 2, 2026: Churchill Capital XI Shareholders Approve Agility Robotics Merger; Business Combination Expected To Raise $465.1M And Nasdaq Trading Under 'AGLT' To Begin November 5 As previously announced, on June 24, 2026, Churchill Capital Corp XI, a Cayman Islands exempted company ("Churchill"), entered into an Agreement and Plan of Merger and Reorganization (the "Merger
globenewswire.com Churchill Capital Corp XI Shareholders Approve Business Combination with Agility Robotics Approximately $465 million in expected gross capital to support Agility's business plan and accelerate commercial deployments Transaction expected to close on November 4, 2026; combined company…
benzinga.com Churchill Stock Explodes: What's Going On? Churchill Capital Corp XI (NASDAQ:CCXI) shares are soaring Monday. The move follows a Friday announcement from the company and Agility Robotics that they expect to raise about $465 million in…
benzinga.com Churchill Stock Explodes: What's Going On? Churchill Capital Corp XI shares are surging Monday. The company and Agility Robotics expect to raise ~$465 million for their merger.
benzinga.com Agility Robotics Expects $465M Gross Raise Through Churchill XI Deal Business combination expected to close on November 4, 2026, subject to Churchill XI shareholder approval; the combined company expected to begin trading on Nasdaq under ticker symbol "AGLT" on…
benzinga.com Churchill Capital's Proposed Merger Partner Agility Robotics Says Digit 5 Will Standardize On NVIDIA IGX Thor For Its Onboard Compute, Expanding Collaboration As Agility Prepares Its Next-Gen Humanoid Robot For Broader Commercial Deployment. Agility Robotics, a leading humanoid robotics and physical AI company, today announced that Digit® 5 will standardize on NVIDIA IGX Thor for its onboard compute, expanding the companies’…
benzinga.com Churchill Capital's Merger Partner Agility Robotics And FORT Robotics Sign MOU Outlining Partnership To Further Advance Safety Infrastructure Of Digit 5 New Offboard Safety Bridge Extends Agility and FORT's Safety Architecture to Digit 5SALEM, Ore. and PHILADELPHIA, Oct. 1, 2026 /PRNewswire/ -- Agility Robotics, a leading humanoid robotics and…
benzinga.com CCXI Gains as Agility’s $300 Million-Plus Orders Strengthen Humanoid Robotics Story CCXI stock rises after Agility Robotics unveils Digit 5, spotlighting its proposed $2.5 billion merger and $300 million-plus orders.
benzinga.com Why CCXI Stock Is Climbing Wednesday Following Unitree's Blockbuster IPO Churchill Capital Corp XI shares are rising Wednesday morning as investors seek liquid, public proxies following the public debut of Unitree.
benzinga.com Churchill Capital Stock Rises as Sponsor Financing Adds Fuel to Agility Robotics Merger Plans Churchill Capital Corp XI rise nearly 5% after securing new working capital as it advances its Agility Robotics merger.
benzinga.com Churchill Capital Corp XI Merger Partner Agility Robotics Appoints Michael Beer CFO, Succeeding Jennifer Hunter, Who Will Transition To COO Exclusively Agility Robotics, a leading humanoid robotics and Physical AI company, today announced the appointment of Michael Beer as Chief Financial Officer as the company continues to strengthen its executive…
benzinga.com Churchill Capital Shares Rise as $2.5 Billion Agility Robotics Merger Keeps Investors Engaged Churchill Capital Corp XI shares are in focus Monday as its planned merger with Agility Robotics continues to attract investor attention.
benzinga.com Progress Software Posts Upbeat Q2 Earnings, Joins PowerFleet, Meta Platforms And Other Big Stocks Moving Higher On Wednesday US stocks fall, Nasdaq down 200 points. Progress Software (NASDAQ: PRGS) shares rise 11.7% after beating earnings estimates. Other top gainers include SOC, UXIN, AIOT, GRND, FWDI, DLO, AIIR, TALO,…
benzinga.com Churchill Capital Stock Is Surging Wednesday: What Investors Need to Know Churchill Capital Corp XI shares are up in Wednesday's premarket as traders weigh the SEC filing details on its Agility Robotics merger.
benzinga.com Churchill Capital Stock Edges Lower Tuesday: What The Latest SEC Filings Reveal Churchill Capital Corp XI is edging lower in Tuesday's premarket, as traders weigh its definitive merger agreement with Agility Robotics.
benzinga.com Iridium Communications, FuelCell Energy, Rocket Lab And Other Big Stocks Moving Higher On Monday Dow Jones gains 350 points, Iridium acquired by Rocket Lab for $8B, big stocks recording gains: QuidelOrtho, FuelCell, Ouster, Viasat, Swarmer, Charter, Prime Medicine, Roblox, Satellogic, Churchill…
benzinga.com Churchill Capital Stock Surges On $2.5B Merger With Agility Robotics: What Investors Need To Know Shares of Churchill Capital Corp XI are trading higher Monday after announcing a $2.5 billion business combination with Agility Robotics.
benzinga.com Why Universe Pharmaceuticals Shares Are Trading Higher By Around 228%; Here Are 20 Stocks Moving Premarket Universe Pharmaceuticals Inc (NASDAQ: UPC) surged 228.4% to $9.72 in pre-market trading after announcing acquisition of Best Praise International for $10.75 million.
benzinga.com Tesla Rival Going Public Via SPAC, Armed With Investments From Nvidia, Amazon A humanoid robotics company and Tesla rival is going public. Here's what's next for the company and why a Tesla rival SPAC merger could work.
benzinga.com KB Home Posts Upbeat Q2 Sales, Joins Inmode, Icon And Other Big Stocks Moving Higher On Wednesday U.S. stocks rose, with Nasdaq up 50 points. KB Home (NYSE: KBH) reported strong Q2 results, shares jumped 16.2%. Other big gainers: WEN, ABSI, RUN, CCXI, ENRD, SFTX, ICCM, INMD, DFH.- benzinga.com Churchill Capital Corp XI And Agility Robotics To Merge In $2.5B SPAC Transaction; Agility To Trade Under Symbol 'AGLT' Operating today in commercial environments with leading enterprises including Schaeffler, GXO, Toyota Motor Manufacturing Canada.Supported by leading strategic investors and partners across the AI,…
benzinga.com Why Leifras Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket Leifras Co Ltd (NASDAQ: LFS) rose in pre-market trading after acquiring SWIFT JAPAN for JPY454.6 million. Other gainers include MGN, VTAK, CUPR, QNRX, CCXI, WEN, BNC, CAST, and ALPS. XCH and TOP were…
benzinga.com 'Agility, Maker of Humanlike Robots, to Go Public in $2.5 Billion SPAC Deal' - WSJ https://www.wsj.com/finance/agility-maker-of-humanlike-robots-to-go-public-in-2-5-billion-spac-deal-62c3cb32
benzinga.com UnitedHealth, Alignment Healthcare, Humana And Other Big Stocks Moving Higher On Tuesday Dow Jones falls 250 points as UnitedHealth Group rises on Medicare reimbursement boost, other stocks also see gains in today's session.- benzinga.com ChemoCentryx's Return On Capital Employed Insights According to data from Benzinga Pro, during Q2, ChemoCentryx's (NASDAQ:CCXI) reported sales totaled $11.76 million. Despite a 18.02% increase in earnings, the company posted a loss of $31.65 million.
benzinga.com Why Jim Cramer Says This Financial Stock Is 'Terrific' On CNBC’s "Mad Money Lightning Round," Jim Cramer said The Charles Schwab Corporation (NYSE: SCHW) is "terrific."- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2022
- benzinga.com Stifel Downgrades ChemoCentryx to Hold, Lowers Price Target to $52 Stifel analyst Dae Gon Ha downgrades ChemoCentryx (NASDAQ:CCXI) from Buy to Hold and lowers the price target from $86 to $52.
- benzinga.com ChemoCentryx: Q2 Earnings Insights ChemoCentryx (NASDAQ:CCXI) reported its Q2 earnings results on Tuesday, August 9, 2022 at 04:05 PM. Here's what investors need to know about the announcement.
- benzinga.com ChemoCentryx Cancels Second Quarter 2022 Financial Results Conference Call ChemoCentryx, Inc., (NASDAQ:CCXI), today announced the cancellation of its second quarter 2022 financial results conference call scheduled for Tuesday, August 9, 2022, at 5:00 p.m. ET. The call is…
- benzinga.com Earnings Scheduled For August 9, 2022 Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.
- benzinga.com Earnings Preview: ChemoCentryx ChemoCentryx (NASDAQ:CCXI) is set to give its latest quarterly earnings report on Tuesday, 2022-08-09. Here's what investors need to know before the announcement. Analysts estimate that ChemoCentryx…
- benzinga.com Where ChemoCentryx Stands With Analysts Over the past 3 months, 4 analysts have published their opinion on ChemoCentryx (NASDAQ:CCXI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a…
- benzinga.com Benzinga's Top Ratings Upgrades, Downgrades For August 5, 2022 Upgrades
- benzinga.com SVB Leerink Downgrades ChemoCentryx to Market Perform, Lowers Price Target to $52 SVB Leerink analyst Joseph Schwartz downgrades ChemoCentryx (NASDAQ:CCXI) from Outperform to Market Perform and lowers the price target from $64 to $52.
- benzinga.com 3 Analysts Have This to Say About ChemoCentryx ChemoCentryx (NASDAQ:CCXI) has observed the following analyst ratings within the last quarter:
- benzinga.com HC Wainwright & Co. Downgrades ChemoCentryx to Neutral, Lowers Price Target to $52 HC Wainwright & Co. analyst Edward White downgrades ChemoCentryx (NASDAQ:CCXI) from Buy to Neutral and lowers the price target from $101 to $52.
benzinga.com Canaccord Genuity Downgrades ChemoCentryx to Hold, Announces $52 Price Target Canaccord Genuity analyst Edward Nash downgrades ChemoCentryx (NASDAQ:CCXI) from Buy to Hold and announces $52 price target.- benzinga.com Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per…
- benzinga.com Raymond James Downgrades ChemoCentryx to Market Perform Raymond James analyst Steven Seedhouse downgrades ChemoCentryx (NASDAQ:CCXI) from Strong Buy to Market Perform.
- benzinga.com Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session.
benzinga.com Gold Tops 1,800; Alibaba Reports Upbeat Results U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 75 points on Thursday- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
benzinga.com Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.- benzinga.com ChemoCentryx Shares Are Jumping 110% Thursday: Here's Why Shares of ChemoCentryx, Inc. (NASDAQ: CCXI) are skyrocketing Thursday following a groundbreaking announcement for the biopharmaceutical company. Why Is It Moving?
- benzinga.com Nasdaq Edges Higher; Crude Oil Falls Sharply U.S. stocks pared some losses midway through trading, with the Nasdaq Composite turning higher on Thursday.
- benzinga.com Dow Drops Over 100 Points; U.S. Trade Deficit Shrinks To This Level In June U.S. stocks traded lower this morning, with the Dow Jones falling more than 100 points on Thursday.
- benzinga.com Canaccord Genuity Assumes ChemoCentryx at Buy, Announces Price Target of $81 Canaccord Genuity analyst Edward Nash assumes ChemoCentryx (NASDAQ:CCXI) with a Buy rating and announces Price Target of $81.